2 Materials and methods 2.1 Experimental design The experiment was conducted at the experimental station of the Institute of Animal Nutrition, Friedrich-Loeffler-Institute (FLI), in Braunschweig, Germany in accordance with the German Animal Welfare Act and permitted by the Lower Saxony State Office for Consumer Protection and Food Safety (LAVES, Oldenburg, Germany) (AZ33.19-42502-04-16/2378)
Patients were excluded if they had a genetic syndrome such as Fragile X, Rett syndrome, Down syndrome or Angelman syndrome or prematurity
L., Janda, J., Mansour, H
For the GLP-1 drug pipeline, 2026 is not a consolidation year
async-only clinical model with no live escalation path
Insulin-like growth factors I and II in healthy man